Individual #00004529

ID_report -
Reference PubMed: van Karnebeek 2014
Remarks 2-generation family, 1 affected, unaffected heterozygous carrier parents and 2 sisters, possible affected brother not available for analysis
Gender M
Consanguinity yes
Country Pakistan
Population -
Age at death -
VIP -
Data_av -
Treatment -
Panel size 1
Diseases CA5AD
Owner name Clara van Karnebeek
Database submission license No license selected
Created by Clara van Karnebeek
Date created 2014-01-28 22:48:38 +01:00 (CET)
Date last edited 2014-06-18 22:43:42 +02:00 (CEST)


Phenotypes

deficiency, carbonic anhydrase VA, hyperammonemia (CA5AD) (CA5AD)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000015945 born at term by Caesarian section (because of placenta previa) as the youngest of five children to first-cousin consanguineous Pakistani parents. 13m, after unremarkable development, he presented with a 1-day history of visual unresponsiveness. At admission, he was encephalopathic with hyperammonemia (258 μmol/L), hyperlactatemia (4.9 mmol/L), with a compensated metabolic acidosis (pH 7.43, pCO224.8 mm Hg, HCO3 -14 mEq/l). His encephalopathy improved after 48 hours of intravenous fluids and antibiotics administered for presumed meningo-encephalitis (cultures were negative). At the age of 16 months, he had a similar crisis; there were no signs of liver injury. Further metabolic investigations are shown in Table 1. Sodium benzoate and L-arginine were initiated with improvement after 48 hours, and he was discharged on a protein-restricted diet. Urea cycle defects (OTC [MIM 311250], CPS1 [MIM 237300], NAGS [MIM 2373100] deficiencies), and PC [MIM 266150], citrin [MIM 605814], and biotinidase [MIM 253260] deficiencies were excluded by molecular or enzymatic analyses. Following these two crises, he has demonstrated good developmental progress with only minor learning difficulties (no formal testing was available). He continues to have infrequent episodes of vomiting and ketoacidosis without hyperammonemia or lactic acidosis; the frequency of these episodes has not increased since the withdrawal of sodium benzoate and arginine therapy at 7y - - Isolated (sporadic) - - - - - Clara van Karnebeek



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000004444 DNA SEQ;SEQ-NG-I Fibroblast - CA5A 1 Clara van Karnebeek



Variants

1 entry on 1 page. Showing entry 1.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
16 Both (homozygous) +/+ - pathogenic g.87924924_87929001del g.87891318_87895395del - - CA5A_000002 4078 bp deletion of exon 6 PubMed: van Karnebeek 2014 - - Germline yes - - - - Clara van Karnebeek CA5A - - - - 6 NM_001739.1:c.619-3420_774+502del - r.(del) p.(Asp207_Gln258del) - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.